Skip to main content
OpenTrials

Clinical trial condition

Narcolepsy

Explore clinical trials studying Narcolepsy. Study availability and eligibility vary by location and protocol.

117 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Narcolepsy trial results

Completed

Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)

NCT03881852

Conditions
Cataplexy, Cataplexy Narcolepsy, Disorders of Excessive Somnolence, +7 more
Locations
  • CONCERT Study Site Birmingham, Alabama, United States
  • CONCERT Study Site Alameda, California, United States
  • CONCERT Study Site Santa Ana, California, United States
  • CONCERT Study Site Boulder, Colorado, United States
View all 14 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)

NCT06358950

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +6 more
Locations
  • Alkermes Investigational Site Los Angeles, California, United States
  • Alkermes Investigational Site Redwood City, California, United States
  • Alkermes Investigator Site San Francisco, California, United States
  • Alkermes Investigational Site Santa Ana, California, United States
View all 45 locations
View Trial Details
Completed

A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy

NCT05059223

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +6 more
Locations
  • Clinical Research Site Alabaster, Alabama, United States
  • Clinical Research Site Peoria, Arizona, United States
  • Clinical Research Site Phoenix, Arizona, United States
  • Clinical Research Site Redwood City, California, United States
View all 50 locations
View Trial Details
Completed

A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With Narcolepsy

NCT05869773

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +4 more
Locations
  • Science 37 Culver City, California, United States
  • M3 Wake Research Encino, California, United States
  • So Cal Clinical Research Huntington Beach, California, United States
  • Long Beach Research Institute Lakewood, California, United States
View all 43 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2

NCT06555783

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +8 more
Locations
  • Alkermes Investigator Site Little Rock, Arkansas, United States
  • Alkermes Investigator Site Los Angeles, California, United States
  • Alkermes Investigator Site Redwood City, California, United States
  • Alkermes Investigator Site San Francisco, California, United States
View all 47 locations
View Trial Details
Completed

Observational Study of LUMRYZ in Narcolepsy

NCT06792708

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +4 more
Locations
  • Jeremy D McConnell, MD PA Bradenton, Florida, United States
  • Comprehensive Sleep Center East Lansing, Michigan, United States
  • Patient First MD Middletown, New Jersey, United States
  • Ghaly Sleep Management Services East Syracuse, New York, United States
View Trial Details

Related conditions